We show that cervical cancer cells can use the CD95 pathway to induce their proliferation; this effect could be due to the activation of signalling pathways such as NFκB and PI3K/MAPK, and likely the JAK/STAT pathway. This evidence concerns the gene NFKB1 and cervical cancer.